What is SHINE?
Founded in 2005 by Greg Piefer, SHINE is a pioneering technology firm dedicated to the practical application of nuclear fusion. The company operates at the intersection of advanced physics and industrial utility, focusing on the development of commercially viable nuclear technology solutions. By moving beyond traditional research paradigms, SHINE has established a robust framework for deploying fusion-based systems that address critical needs in energy, medical isotope production, and industrial material testing. Its market position is defined by a unique, growth-oriented approach that prioritizes scalability and safety, distinguishing it from academic or purely experimental fusion ventures.
How much funding has SHINE raised?
SHINE has raised a total of $796.8M across 10 funding rounds:
Debt
$6.9M
Series B
$30M
Corporate Investment
$50M
Debt
$1M
Unspecified
$94.6M
Series C
$150M
Other Financing Round
$70M
Private Equity
$240M
Debt (2017): $6.9M, investors not publicly disclosed
Series B (2018): $30M, investors not publicly disclosed
Corporate Investment (2019): $50M backed by Oaktree Capital Management L.P.
Debt (2020): $1M with participation from PPP
Unspecified (2021): $94.6M, investors not publicly disclosed
Series C (2021): $150M supported by Koch Disruptive Technologies, Fidelity, and Baillie Gifford
Other Financing Round (2023): $70M featuring Fidelity and Baillie Gifford
Private Equity (2026): $240M backed by NantWorks, Fidelity Investments (FMR, Oaktree Capital Management, Deerfield, Pelican Energy Partners, and Sumitomo Corporation of Americas
Key Investors in SHINE
Fidelity Investments (FMR)
A global financial services powerhouse providing comprehensive investment, wealth management, and retirement solutions to institutional and individual clients.
NantWorks
A research and development firm specializing in advanced technology integration, including supercomputing, machine vision, and next-generation networks for healthcare and commerce.
Oaktree Capital Management
A leading global investment management firm known for its opportunistic, value-oriented approach to credit, equity, and real estate markets.
What's next for SHINE?
With the recent influx of capital, SHINE is well-positioned to accelerate its strategic roadmap, focusing on the expansion of its production facilities and the refinement of its proprietary fusion technology. The company is expected to prioritize the commercialization of its core platforms, aiming to achieve greater operational efficiency and market penetration in the energy and healthcare sectors. Future growth will likely be characterized by increased investment in R&D, the strengthening of its supply chain, and the pursuit of long-term partnerships that align with its mission to improve the world through nuclear innovation. As the company scales, it remains focused on maintaining its competitive edge in the high-barrier-to-entry nuclear market.
See full SHINE company page
